Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00357916 · ClinicalTrials.gov registry record · Phase 1
Study to Determine the Sensitizing Potential of PEP005 Topical Gel in Healthy Volunteers Using a Repeat Insult Patch Test Design
A Phase 1 study, sponsored by Peplin.
- Completed
- Registry status
- Phase 1
- Development phase
- 200
- Enrollment target
NCT00357916: Completed Phase 1 study, sponsored by Peplin.
NCT00357916 is a Phase 1 study that has completed, run by Peplin. The registered enrollment target is 200 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (233% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00357916, a Phase 1 study, has completed, sponsored by Peplin.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 200 participants
- Enrollment target
Study Summary
To determine the sensitisation potential of PEP005 Topical Gel (0.01% concentration) on normal skin To evaluate skin irritation
Interventions
- DRUG PEP005 Topical Gel (0.01% concentration)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2006-06 |
| Est. Completion | 2006-10 |
| Phase | Phase 1 |
What the finished NCT00357916 record still lists
NCT00357916 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (233% higher).
The record links to 0 conditions, and to 1 intervention - of which PEP005 Topical Gel (0.01% concentration) is the first listed.
NCT00357916 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00357916 about?
NCT00357916 is a clinical study titled "Study to Determine the Sensitizing Potential of PEP005 Topical Gel in Healthy Volunteers Using a Repeat Insult Patch Test Design". To determine the sensitisation potential of PEP005 Topical Gel (0.01% concentration) on normal skin To evaluate skin irritation
What is the current status of trial NCT00357916?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 200 participants. The study started on 2006-06. Estimated completion is 2006-10.
What interventions are being tested in trial NCT00357916?
The interventions under investigation include: PEP005 Topical Gel (0.01% concentration) (DRUG).
Who is sponsoring clinical trial NCT00357916?
This trial is sponsored by Peplin, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00357916's enrollment target sits among peer trials
200 259th of 2000 higher than 1,724 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia